miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma
Authors
Keywords
-
Journal
Future Oncology
Volume 14, Issue 17, Pages 1741-1753
Publisher
Future Medicine Ltd
Online
2018-03-08
DOI
10.2217/fon-2018-0064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer
- (2017) Michaela Strotbek et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia
- (2017) Yan Guo et al. LEUKEMIA & LYMPHOMA
- MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma
- (2017) Y-S Liu et al. ONCOGENE
- Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell
- (2016) Hironori Ushijima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer
- (2016) Fei Tian et al. GENE
- GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
- (2016) Paola Martinelli et al. GUT
- The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients
- (2016) Sebastian Fantini et al. Oncotarget
- GATA6 is overexpressed in breast cancer and promotes breast cancer cell epithelial–mesenchymal transition by upregulating slug expression
- (2015) Yongchun Song et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression
- (2015) Weizhao Peng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Extensive sequence variation in the 3′ untranslated region of theKRASgene in lung and ovarian cancer cases
- (2014) Minlee Kim et al. CELL CYCLE
- miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma
- (2014) Xing Yu et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center
- (2014) Jesper Brandstorp-Boesen et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2
- (2014) Ping Huang et al. TUMOR BIOLOGY
- Clinical update on cancer: molecular oncology of head and neck cancer
- (2014) Y Suh et al. Cell Death & Disease
- microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression
- (2014) SHI-JUN TONG et al. Experimental and Therapeutic Medicine
- miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
- (2013) Martin Pichler et al. JOURNAL OF CLINICAL PATHOLOGY
- miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma
- (2011) Cheng-Chieh Yang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Overexpression of SATB1 in Laryngeal Squamous Cell Carcinoma
- (2010) Xu-Dong Zhao et al. ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery
- TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
- (2009) B Wang et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started